<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>About 70% of children with <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> may be cured by conventional chemotherapy </plain></SENT>
<SENT sid="1" pm="."><plain>The prognosis is considerably worse in infant <z:hpo ids='HP_0001909'>leukemia</z:hpo> with a translocation t(4;11) </plain></SENT>
<SENT sid="2" pm="."><plain>We report an infant with a diagnosis of cytochemically undifferentiated <z:hpo ids='HP_0011009'>acute</z:hpo> hybrid <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">pre pre B-ALL</z:e> coexpressing one myelomonocytic marker) and t(4;11) </plain></SENT>
<SENT sid="3" pm="."><plain>Initial clinical presentation and the course of the disease were typical for t(4;11) <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>After an early hematologic relapse intensive chemotherapy resulted only in a second partial remission 7 months after initial diagnosis </plain></SENT>
<SENT sid="5" pm="."><plain>Subsequent bone marrow transplantation with 16 mg/kg <z:chebi fb="0" ids="28901">busulfan</z:chebi> and 200 mg/kg <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> followed by the infusion of autologous purged bone marrow resulted in a continuous second remission which has lasted 46 months so far </plain></SENT>
</text></document>